93 related articles for article (PubMed ID: 26165932)
1. Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).
Mclaughlin T; Oscar-Berman M; Simpatico T; Giordano J; Jones S; Barh D; Downs WB; Waite RL; Madigan M; Dushaj K; Lohmann R; Braverman ER; Han D; Blum K
J Behav Addict; 2013 Jun; 2(2):117-24. PubMed ID: 26165932
[TBL] [Abstract][Full Text] [Related]
2. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
[TBL] [Abstract][Full Text] [Related]
3. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: a hypothesis.
Blum K; Chen TJ; Meshkin B; Waite RL; Downs BW; Blum SH; Mengucci JF; Arcuri V; Braverman ER; Palomo T
Med Hypotheses; 2007; 69(5):1054-60. PubMed ID: 17467918
[TBL] [Abstract][Full Text] [Related]
5. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
6. Hypothesizing that, A Pro-Dopamine Regulator (KB220Z) Should Optimize, but Not Hyper-Activate the Activity of Trace Amine-Associated Receptor 1 (TAAR-1) and Induce Anti-Craving of Psychostimulants in the Long-Term.
Blum K; Badgaiyan RD; Braverman ER; Dushaj K; Li M; Thanos PK; Demetrovics Z; Febo M
J Reward Defic Syndr Addict Sci; 2016; 2(1):14-21. PubMed ID: 28317038
[TBL] [Abstract][Full Text] [Related]
7. [Crime prevention in high-functioning pervasive developmental disorders with paraphilia].
Ueno C; Oda H; Inoue M; Ariki N; Hasaba M; Kinoshita T
Seishin Shinkeigaku Zasshi; 2007; 109(7):637-53. PubMed ID: 17877031
[TBL] [Abstract][Full Text] [Related]
8. Reward deficiency syndrome: genetic aspects of behavioral disorders.
Comings DE; Blum K
Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
[TBL] [Abstract][Full Text] [Related]
9. Genotrim, a DNA-customized nutrigenomic product, targets genetic factors of obesity: hypothesizing a dopamine-glucose correlation demonstrating reward deficiency syndrome (RDS).
Blum K; Chen TJ; Meshkin B; Downs BW; Gordon CA; Blum S; Mangucci JF; Braverman ER; Arcuri V; Deutsch R; Pons MM
Med Hypotheses; 2007; 68(4):844-52. PubMed ID: 17071010
[TBL] [Abstract][Full Text] [Related]
10. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
[TBL] [Abstract][Full Text] [Related]
11. Tourette's disorder and associated complex behaviors: a case report.
McDougle CJ; Southwick SM; Rohrbaugh RM
Yale J Biol Med; 1990; 63(3):209-14. PubMed ID: 2238716
[TBL] [Abstract][Full Text] [Related]
12. [Control of inner speech and Gilles de la Tourette's syndrome].
Vercueil L
Encephale; 2003; 29(5):460-2. PubMed ID: 14615696
[TBL] [Abstract][Full Text] [Related]
13. Gilles de la Tourette's syndrome: biochemical approaches.
Van Woert MH; Jutkowitz R; Rosenbaum D; Bowers MB
Res Publ Assoc Res Nerv Ment Dis; 1976; 55():459-65. PubMed ID: 1070064
[TBL] [Abstract][Full Text] [Related]
14. "Sleeping Beauty paraphilia": deviant desire in the context of bodily self-image disturbance in a patient with a fronto-parietal traumatic brain injury.
Bianchi-Demicheli F; Rollini C; Lovblad K; Ortigue S
Med Sci Monit; 2010 Feb; 16(2):CS15-7. PubMed ID: 20110923
[TBL] [Abstract][Full Text] [Related]
15. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
[TBL] [Abstract][Full Text] [Related]
16. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
[TBL] [Abstract][Full Text] [Related]
17. Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette's adults.
Yeh CB; Lee CH; Chou YH; Chang CJ; Ma KH; Huang WS
Nucl Med Commun; 2006 Oct; 27(10):779-84. PubMed ID: 16969259
[TBL] [Abstract][Full Text] [Related]
18. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder.
Miguel EC; Coffey BJ; Baer L; Savage CR; Rauch SL; Jenike MA
J Clin Psychiatry; 1995 Jun; 56(6):246-55. PubMed ID: 7775367
[TBL] [Abstract][Full Text] [Related]
19. Considerations of natural history and pathophysiology in the psychopharmacology of Tourette's syndrome.
Peterson BS
J Clin Psychiatry; 1996; 57 Suppl 9():24-34. PubMed ID: 8823347
[TBL] [Abstract][Full Text] [Related]
20. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
Blum K; Gold MS
Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
